|
US8563522B2
(en)
|
1997-07-08 |
2013-10-22 |
The Iams Company |
Method of maintaining and/or attenuating a decline in quality of life
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US7182943B2
(en)
*
|
2002-05-15 |
2007-02-27 |
UNIVERSITé LAVAL |
Method and system for modulation of microbial cell characteristics
|
|
EP1384483A1
(en)
*
|
2002-07-23 |
2004-01-28 |
Nestec S.A. |
Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
|
|
SE526711C2
(sv)
*
|
2003-01-31 |
2005-10-25 |
Probi Ab |
Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
|
|
US20040197304A1
(en)
|
2003-04-01 |
2004-10-07 |
The Procter & Gamble Company And Alimentary Health, Ltd. |
Methods of determining efficacy of treatments of inflammatory diseases of the bowel
|
|
EP2287616A1
(en)
*
|
2003-09-15 |
2011-02-23 |
Oklahoma Medical Research Foundation |
Method of using cytokine assays to diagnose, treat, and evaluate systemic lupus erythematosus
|
|
WO2005030230A1
(en)
*
|
2003-09-30 |
2005-04-07 |
Probiomics Limited |
Compositions and methods for treatment or prevention of psoriasis and related disorders
|
|
GB0323039D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Danisco |
Method
|
|
US8871266B2
(en)
|
2003-10-01 |
2014-10-28 |
Commonwealth Scientific & Industrial Research Organisation |
Probiotic storage and delivery
|
|
AU2004275438B2
(en)
*
|
2003-10-01 |
2008-05-29 |
Commonwealth Scientific & Industrial Research Organisation |
Probiotic storage and delivery
|
|
AU2004298384A1
(en)
|
2003-12-17 |
2005-06-30 |
N.V. Nutricia |
Lactic acid producing bacteria and lung function
|
|
US7785635B1
(en)
|
2003-12-19 |
2010-08-31 |
The Procter & Gamble Company |
Methods of use of probiotic lactobacilli for companion animals
|
|
US8877178B2
(en)
|
2003-12-19 |
2014-11-04 |
The Iams Company |
Methods of use of probiotic bifidobacteria for companion animals
|
|
US8894991B2
(en)
|
2003-12-19 |
2014-11-25 |
The Iams Company |
Canine probiotic Lactobacilli
|
|
US20050158294A1
(en)
|
2003-12-19 |
2005-07-21 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria pseudolongum
|
|
US20050152884A1
(en)
|
2003-12-19 |
2005-07-14 |
The Procter & Gamble Company |
Canine probiotic Bifidobacteria globosum
|
|
WO2005072718A1
(ja)
*
|
2004-01-28 |
2005-08-11 |
Kurume University |
乳清発酵物を含有する医薬組成物
|
|
JP2005247780A
(ja)
*
|
2004-03-05 |
2005-09-15 |
Masakazu Maruyama |
ウイルス性肝炎治療剤
|
|
ES2262418B1
(es)
*
|
2004-12-28 |
2007-11-01 |
Consejo Superior Investig. Cientificas |
Extractos proteicos con amplio espectro de actividad antibacteriana y cepas del genero bifidobacterium que los producen.
|
|
TW200700074A
(en)
*
|
2005-03-04 |
2007-01-01 |
Calpis Co Ltd |
Inducer of t cell apoptosis
|
|
WO2006097949A1
(en)
*
|
2005-03-16 |
2006-09-21 |
Actial Farmacêutica, Lda. |
Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
|
|
AU2011205121B2
(en)
*
|
2005-04-08 |
2012-07-05 |
Alimentary Health Ltd |
Method of use of orally administered probiotic bifidobacteria for human beauty benefits
|
|
AU2006235307B2
(en)
|
2005-04-08 |
2011-07-14 |
Alimentary Health Ltd |
Methods of use of orally administered probiotic Bifidobacteria for human beauty benefits
|
|
ES2325887T3
(es)
*
|
2005-05-16 |
2009-09-23 |
Universite De Liege |
Especie bifidobacteriana probiotica.
|
|
ATE512211T1
(de)
|
2005-05-31 |
2011-06-15 |
Iams Company |
Feline probiotische lactobacilli
|
|
AU2006253007B2
(en)
|
2005-05-31 |
2012-12-20 |
Alimentary Health Ltd |
Feline probiotic Bifidobacteria
|
|
EP1967196A4
(en)
|
2005-11-18 |
2009-10-14 |
Idemitsu Kosan Co |
BACILLUS THURINGIENSIS CONTAINING MEANS FOR THE CONTROL OF HARMFUL BACTERIA
|
|
GB0524103D0
(en)
|
2005-11-26 |
2006-01-04 |
Medical Res Council |
Healing
|
|
US7943328B1
(en)
|
2006-03-03 |
2011-05-17 |
Prometheus Laboratories Inc. |
Method and system for assisting in diagnosing irritable bowel syndrome
|
|
EP2002842B1
(en)
*
|
2006-03-31 |
2012-04-11 |
Morinaga Milk Industry Co., Ltd. |
Method for production of the interleukin production regulator
|
|
US20080085524A1
(en)
*
|
2006-08-15 |
2008-04-10 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
|
US20100094560A1
(en)
*
|
2006-08-15 |
2010-04-15 |
Prometheus Laboratories Inc. |
Methods for diagnosing irritable bowel syndrome
|
|
WO2008053444A2
(en)
*
|
2006-11-01 |
2008-05-08 |
The Procter & Gamble Company |
Treating a respiratory condition with bifidobacterium
|
|
CA2675729C
(en)
*
|
2007-01-17 |
2015-05-12 |
Meiji Dairies Corporation |
Prophylactic and/or therapeutic agent for functional gastrointestinal disorders
|
|
EP2124966B1
(en)
|
2007-02-01 |
2015-09-09 |
IAMS Europe B.V. |
Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
|
|
WO2008106373A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Mead Johnson Nutrition Company |
Product containing inactivated probiotic for children or infants
|
|
BRPI0809448A2
(pt)
*
|
2007-03-28 |
2014-09-09 |
Alimentary Health Ltd |
Cepas de bifidobacterium probióticas
|
|
CA2682242A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Alimentary Health Limited |
Probiotic bifidobacterium longum strain
|
|
ES2578261T3
(es)
*
|
2007-05-18 |
2016-07-22 |
Nestec S.A. |
Lactobacillus johnsonii para prevenir infecciones postoperatorias
|
|
EP2522358B1
(en)
|
2007-06-27 |
2016-11-09 |
Laboratorios Ordesa, S.l. |
Peptides against rotavirus infection
|
|
EP2065048A1
(en)
*
|
2007-11-30 |
2009-06-03 |
Institut Pasteur |
Use of a L. casei strain, for the preparation of a composition for inhibiting mast cell activation
|
|
ES2343499B1
(es)
*
|
2007-12-24 |
2011-06-10 |
Consejo Superior De Investigaciones Cientificas |
Microorganismos para mejorar el estado de salud de individuos con desordenes relacionados con la ingesta de gluten.
|
|
US9771199B2
(en)
|
2008-07-07 |
2017-09-26 |
Mars, Incorporated |
Probiotic supplement, process for making, and packaging
|
|
US20110189149A1
(en)
*
|
2008-06-20 |
2011-08-04 |
Remy Burcelin |
New Uses of Lactic Acid Bacteria and Bifidobacteria
|
|
EP3181134B1
(en)
*
|
2009-06-19 |
2019-10-30 |
DuPont Nutrition Biosciences ApS |
Bifidobacteria for treating diabetes and related conditions
|
|
US10104903B2
(en)
|
2009-07-31 |
2018-10-23 |
Mars, Incorporated |
Animal food and its appearance
|
|
TR201807143T4
(tr)
*
|
2009-08-25 |
2018-06-21 |
Nestec Sa |
Bifidobacterium longum ve fonksiyonel gastrointestinal bozukluklar.
|
|
EP2485744A4
(en)
*
|
2009-10-09 |
2014-01-22 |
Prothera Inc |
COMPOSITIONS AND METHODS COMPRISING THE PEDIOCOCCUS TO REDUCE AT LEAST ONE SYMPTOM ASSOCIATED WITH DEVELOPMENT-INVASIVE DISORDER IN A PERSON IN WHICH A DEVELOPMENT-INVASIVE DISORDER HAS BEEN DIAGNOSED
|
|
CN107574131A
(zh)
*
|
2009-11-11 |
2018-01-12 |
营养健康有限公司 |
益生菌双歧杆菌菌株
|
|
WO2011148219A1
(en)
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving the enteric nervous system
|
|
WO2011148220A1
(en)
|
2010-05-28 |
2011-12-01 |
Compagnie Gervais Danone |
Probiotic strains for use in improving transepithelial resistance
|
|
PH12013500224A1
(en)
|
2010-08-04 |
2013-04-08 |
Borody Thomas J |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
WO2012031186A1
(en)
|
2010-09-03 |
2012-03-08 |
Wisconsin Pharmacal Company, Llc. |
Prebiotic suppositories
|
|
ES2389547B1
(es)
*
|
2010-12-07 |
2013-08-08 |
Consejo Superior De Investigaciones Científicas (Csic) |
Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
|
|
CN103370073B
(zh)
|
2010-12-17 |
2017-12-05 |
热尔韦·达诺尼公司 |
用于改善消化状况的乳酸乳球菌菌株
|
|
MX2013010343A
(es)
|
2011-03-09 |
2014-04-30 |
Univ Minnesota |
Composicion y metodos para el transplante de microbiota de colon.
|
|
CN102899261B
(zh)
*
|
2011-03-11 |
2016-12-07 |
光晟生物科技股份有限公司 |
长双歧杆菌长亚种br022菌株的用途
|
|
GB201112091D0
(en)
|
2011-07-14 |
2011-08-31 |
Gt Biolog Ltd |
Bacterial strains isolated from pigs
|
|
GB201117313D0
(en)
|
2011-10-07 |
2011-11-16 |
Gt Biolog Ltd |
Bacterium for use in medicine
|
|
CN104364394B
(zh)
*
|
2012-03-17 |
2019-02-22 |
加州大学评议会 |
痤疮的快速诊断和个体化治疗
|
|
WO2013176774A1
(en)
|
2012-05-25 |
2013-11-28 |
Arizona Board Of Regents |
Microbiome markers and therapies for autism spectrum disorders
|
|
GB201306536D0
(en)
|
2013-04-10 |
2013-05-22 |
Gt Biolog Ltd |
Polypeptide and immune modulation
|
|
ITMI20131467A1
(it)
*
|
2013-09-06 |
2015-03-07 |
Sofar Spa |
Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico
|
|
CN106414709A
(zh)
|
2014-01-24 |
2017-02-15 |
宝洁公司 |
包含微生物的长丝及其制备方法
|
|
US20150209468A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Hygiene article containing microorganism
|
|
US20150209469A1
(en)
|
2014-01-24 |
2015-07-30 |
The Procter & Gamble Company |
Web Comprising a Microorganism-Containing Fibrous Element and Methods for Making Same
|
|
MA39710A
(fr)
|
2014-04-23 |
2015-10-29 |
Sofar Spa |
Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
|
|
WO2016102950A1
(en)
*
|
2014-12-23 |
2016-06-30 |
4D Pharma Research Limited |
Immune modulation
|
|
SG11201704814SA
(en)
|
2014-12-23 |
2017-07-28 |
4D Pharma Res Ltd |
Pirin polypeptide and immune modulation
|
|
CA2985827A1
(en)
|
2015-05-14 |
2016-11-17 |
Crestovo Holdings Llc |
Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
|
|
AU2016268158B2
(en)
|
2015-05-22 |
2022-03-17 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US20160354507A1
(en)
|
2015-06-07 |
2016-12-08 |
The Procter & Gamble Company |
Article of commerce containing absorbent article
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
HRP20191949T1
(hr)
|
2015-06-15 |
2020-01-24 |
4D Pharma Research Limited |
Blautia stercosis i wexlerae za upotrebu u liječenju upalnih i autoimunih bolesti
|
|
WO2016203221A1
(en)
|
2015-06-15 |
2016-12-22 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
ME03511B
(me)
|
2015-06-15 |
2020-04-20 |
4D Pharma Res Ltd |
Kompozicije koje sadrže bakterijske sojeve
|
|
US20170020750A1
(en)
|
2015-07-23 |
2017-01-26 |
The Procter & Gamble Company |
Patch containing microorganism
|
|
HK1254843B
(zh)
|
2015-11-20 |
2020-04-17 |
希杰生物科技株式会社 |
包含细菌菌株的组合物
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
SG10201913557TA
(en)
|
2016-03-04 |
2020-02-27 |
4D Pharma Plc |
Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
|
|
GB201612191D0
(en)
|
2016-07-13 |
2016-08-24 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
EP3448398A4
(en)
|
2016-04-21 |
2019-12-18 |
Naked Biome, Inc. |
COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES
|
|
IT201600083376A1
(it)
|
2016-08-08 |
2018-02-08 |
Sofar Spa |
Uso di probiotici per aumentare l’assorbimento proteico
|
|
ITUA20164188A1
(it)
|
2016-06-08 |
2017-12-08 |
Sofar Spa |
Nuovo uso medico di probiotici
|
|
US20170360848A1
(en)
|
2016-06-15 |
2017-12-21 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Methods for treating autism spectrum disorder and associated symptoms
|
|
US10849936B2
(en)
|
2016-07-01 |
2020-12-01 |
Regents Of The University Of Minnesota |
Compositions and methods for C. difficile treatment
|
|
TWI802545B
(zh)
|
2016-07-13 |
2023-05-21 |
英商4D製藥有限公司 |
包含細菌菌株之組合物
|
|
US20180036352A1
(en)
|
2016-08-03 |
2018-02-08 |
Crestovo Holdings Llc |
Methods for treating ulcerative colitis
|
|
WO2018071537A1
(en)
|
2016-10-11 |
2018-04-19 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US10092601B2
(en)
|
2016-10-11 |
2018-10-09 |
Crestovo Holdings Llc |
Compositions and methods for treating multiple sclerosis and related disorders
|
|
US11213549B2
(en)
|
2016-10-11 |
2022-01-04 |
Finch Therapeutics Holdings Llc |
Compositions and method for treating primary sclerosing cholangitis and related disorders
|
|
IT201600122724A1
(it)
|
2016-12-02 |
2018-06-02 |
Sofar Spa |
Exopolysaccharides and uses thereof
|
|
GB201621123D0
(en)
|
2016-12-12 |
2017-01-25 |
4D Pharma Plc |
Compositions comprising bacterial strains
|
|
IT201600127498A1
(it)
|
2016-12-16 |
2018-06-16 |
Sofar Spa |
Probiotici per uso nella diverticolosi e malattia diverticolare
|
|
CN110352237B
(zh)
*
|
2017-02-28 |
2023-01-10 |
精密生物集团有限公司 |
可以有益地调节针对呼吸道病毒感染的免疫应答的长双歧杆菌
|
|
EP3589726A1
(en)
|
2017-02-28 |
2020-01-08 |
Alimentary Health Limited |
Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
|
|
WO2018187464A1
(en)
|
2017-04-05 |
2018-10-11 |
Crestovo Holdings Llc |
Compositions and methods for treating diverticulitis and related disorders
|
|
CN110831606A
(zh)
|
2017-04-05 |
2020-02-21 |
克雷斯顿沃控股公司 |
治疗帕金森氏病(pd)和相关疾病的组合物和方法
|
|
ES2877726T3
(es)
|
2017-05-22 |
2021-11-17 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
EP3630942B1
(en)
|
2017-05-24 |
2022-11-30 |
4D Pharma Research Limited |
Compositions comprising bacterial strain
|
|
JP2020521760A
(ja)
|
2017-05-26 |
2020-07-27 |
クレストヴォ・ホールディングス・エルエルシー |
糞便微生物ベースの治療剤を含む凍結乾燥組成物ならびにそれを製造および使用する方法
|
|
ES2841902T3
(es)
|
2017-06-14 |
2021-07-12 |
4D Pharma Res Ltd |
Composiciones que comprenden cepas bacterianas
|
|
TWI812624B
(zh)
|
2017-06-14 |
2023-08-21 |
南韓商希杰生物科技股份有限公司 |
包含細菌品系之組成物
|
|
PL3600363T3
(pl)
|
2017-06-14 |
2021-06-14 |
4D Pharma Research Limited |
Kompozycje zawierające szczepy bakteryjne
|
|
MA51770A
(fr)
|
2017-07-05 |
2020-05-13 |
Evelo Biosciences Inc |
Compositions et méthodes de traitement du cancer à l'aide de bifidobacterium animalis ssp. lactis
|
|
WO2019032573A1
(en)
|
2017-08-07 |
2019-02-14 |
Finch Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR MAINTAINING AND RESTORING A HEALTHY INTESTINAL BARRIER
|
|
JP7285096B2
(ja)
*
|
2018-03-28 |
2023-06-01 |
森永乳業株式会社 |
ストレス緩和用組成物並びに該ストレス緩和用組成物を用いた医薬品組成物及び飲食品組成物
|
|
CN108570434A
(zh)
*
|
2018-05-10 |
2018-09-25 |
苏州博悦曼环保科技有限公司 |
高效降解餐厨垃圾的复合菌剂及其制造方法
|
|
US11166990B2
(en)
|
2018-07-13 |
2021-11-09 |
Finch Therapeutics Holdings Llc |
Methods and compositions for treating ulcerative colitis
|
|
US11911419B2
(en)
|
2018-09-27 |
2024-02-27 |
Finch Therapeutics Holdings Llc |
Compositions and methods for treating epilepsy and related disorders
|
|
CN109929773B
(zh)
*
|
2019-01-10 |
2020-06-19 |
江苏德禧生物科技有限公司 |
一株可用于富硒培养的双歧杆菌及其活性蛋白和应用
|
|
CN111411093B
(zh)
*
|
2019-04-30 |
2021-10-22 |
中国科学院天津工业生物技术研究所 |
活性提高的磷酸转酮酶及在生产代谢物中的应用
|
|
US12290538B2
(en)
|
2019-07-19 |
2025-05-06 |
Finch Therapeutics Holdings Llc |
Methods and products for treatment of gastrointestinal disorders
|
|
US11751597B2
(en)
|
2019-11-05 |
2023-09-12 |
Alfasigma S.P.A. |
Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems
|
|
EP4117697A1
(en)
|
2020-03-13 |
2023-01-18 |
PrecisionBiotics Group Limited |
Bifidobacterium longum
|
|
CN116083327B
(zh)
*
|
2023-04-07 |
2023-06-09 |
天赋能(天津)功能食品研究发展有限公司 |
长双歧杆菌婴儿亚种及在缓解便秘、抗结肠组织炎症和改善肠道菌群方面的应用
|
|
CN116574659A
(zh)
*
|
2023-06-14 |
2023-08-11 |
江南大学 |
一株可缓解类风湿性关节炎的长双歧杆菌婴儿亚种及其应用
|